C5AR1 and Encephalopathy: Based on the established functions of C5a in the pathophysiology of sepsis and on experimental data which imply C5a is a potent mediator of BBB damage and neuroinflammation, we designed the present study to investigate the effect of antibody-mediated C5a-blockade on preventing the development of encephalopathy in experimental sepsis.